Can Turmeric Improve Blood Vessel Function? What the Trials Show

Written by the Nuvirox Research Team

Short answer: curcumin appears to improve blood vessel function in healthy aging adults, with honest caveats. Multiple small trials measuring flow-mediated dilation — a direct ultrasound test of how well an artery widens in response to increased blood flow — found meaningful improvements after curcumin supplementation in healthy older adults and postmenopausal women. A larger, longer trial in people with chronic kidney disease found no benefit, so this isn't a universal effect.

What is "endothelial function" and why does it matter?

The endothelium is the thin layer of cells lining every blood vessel. Healthy endothelium releases nitric oxide, which relaxes vessel walls and allows arteries to widen (dilate) when blood flow increases — measured clinically as flow-mediated dilation (FMD). Endothelial function declines with age and with cardiovascular risk factors, and reduced FMD independently predicts future cardiovascular events. It's one of the earliest measurable signs of vascular aging, well before a blood pressure cuff or cholesterol panel would flag a problem.

How would a spice compound affect artery function?

Curcumin's antioxidant activity is thought to reduce oxidative degradation of nitric oxide, preserving more of it to do its vessel-relaxing job. Human trials have directly tested this using forearm blood flow studies and brachial artery ultrasound — measuring the mechanism, not just guessing at it from downstream markers.

Does the effect actually show up on ultrasound, or is this theoretical?

It shows up in several controlled trials, at least in specific populations. The two most direct studies used real vascular imaging (flow-mediated dilation via brachial artery ultrasound and forearm blood flow via infusion studies), not just blood biomarkers.

How does this connect to curcumin's other cardiovascular research?

Vascular function sits alongside, but is distinct from, the lipid and cholesterol research covered elsewhere in this cluster — flow-mediated dilation measures how the vessel itself behaves, not what's circulating inside it. A person could theoretically see one improve without the other, which is part of why researchers increasingly measure both rather than assuming lipid changes translate directly into vessel function changes. It also means the practical takeaway is narrower than "good for heart health" broadly — the trials reviewed here specifically measured artery responsiveness, not heart attack or stroke rates, which no curcumin trial has been large or long enough to assess.

What made the exercise-comparison trial noteworthy?

Most supplement trials compare an active ingredient only against placebo. The postmenopausal women's trial instead ran three arms side by side — curcumin, structured aerobic exercise, and untreated control — which lets you compare curcumin's effect size against an intervention with an extremely well-established evidence base. Finding a similar magnitude of improvement between the two groups is a genuinely interesting signal, though it's a single small trial (32 women) and shouldn't be read as curcumin being a substitute for exercise rather than a separate intervention that happened to produce a comparable result in this one study. For a broader look at curcumin's cardiovascular research beyond vessel function specifically, see our review of curcumin and cholesterol and heart health.

What Human Studies Actually Show

Healthy older adults, randomized, placebo-controlled (39 patients, 12 weeks). Men and postmenopausal women aged 45–74 took 2,000 mg/day of a bioavailable curcumin formulation or placebo. Forearm blood flow response to acetylcholine — a direct test of resistance-artery endothelial function — increased 37% with curcumin (p=0.03) but not placebo. Brachial artery flow-mediated dilation increased 36% in the curcumin group (from 4.4% to 5.7% dilation, p=0.001), with no change in placebo.

Postmenopausal women, three-arm trial (32 women, 8 weeks). This trial directly compared curcumin ingestion against aerobic exercise training and a no-intervention control. Flow-mediated dilation increased significantly and to a similar degree in both the curcumin and exercise groups, with no change in the control group — suggesting curcumin's effect size was comparable to a structured exercise program over the same period.

Meta-analysis of five RCTs. Pooling five randomized trials, curcumin preparations showed a significant, large effect size on improving FMD overall. Notably, the effect was much smaller in smokers than non-smokers, suggesting background oxidative stress load may blunt the benefit.

Honest counterweight — chronic kidney disease trial (88 patients, 12 months). In a longer and larger trial specifically in people with stage 3b–4 CKD, 2,000 mg/day of curcumin for a full year produced no improvement in flow-mediated dilation, arterial stiffness, or cognitive function compared to placebo. This is a meaningfully different population (older, sicker, with more entrenched vascular disease) and a much longer duration than the positive trials, and it's a reminder that a positive signal in healthy adults doesn't automatically generalize to people with established disease.

What curcumin won't do for artery health

Curcumin has not been shown to reverse established atherosclerosis or replace blood pressure or cholesterol treatment, and the null result in chronic kidney disease patients suggests it may not help once vascular disease is more advanced. See a doctor before starting any new supplement if you have diagnosed cardiovascular disease, kidney disease, or take blood thinners, since curcumin can have mild antiplatelet effects.

Dosing in the trials

The positive trials used 2,000 mg/day of a bioavailable curcumin formulation (Longvida) for 12 weeks, or lower oral doses for 8 weeks in the exercise-comparison trial. The null CKD trial used the same 2,000 mg/day Longvida dose but for a full 12 months — so duration and dose don't fully explain the difference; population health status appears to matter.

Frequently Asked Questions

What is flow-mediated dilation and why do researchers measure it?
It's an ultrasound measurement of how much an artery widens after a few minutes of blocked blood flow are released. It's a validated, direct marker of vascular health that predicts future cardiovascular risk.

Does this mean curcumin lowers blood pressure?
Not necessarily the same thing — flow-mediated dilation measures vessel responsiveness, not resting blood pressure. Some trials measure both, but they're distinct outcomes.

Why did the kidney disease trial find nothing when other trials found benefits?
The CKD trial studied an older, sicker population over a full year, versus 8–12 weeks in healthy adults — suggesting curcumin's vascular benefit may not extend to more advanced or established vascular disease.

Does smoking affect whether curcumin helps artery function?
The meta-analysis of five trials found a substantially smaller effect in smokers than non-smokers, suggesting higher background oxidative stress may blunt curcumin's measured benefit.

Is this the same research as curcumin for cholesterol?
No — flow-mediated dilation is a distinct, direct measurement of vessel function itself, separate from cholesterol or lipid panel research, though both relate to overall cardiovascular risk.

FROM NUVIROX

Why we formulated Turmeric with BioPerine

Turmeric with BioPerine is built around the standardized curcuminoid dose ranges studied in the human trials referenced throughout this article, formulated for consistency and absorption. We stand behind it with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.

Learn more about Turmeric with BioPerine →

Related reading in this series: Can Curcumin Help With Metabolic Syndrome? What the Trials Show; Can Curcumin Protect the Kidneys in Chronic Kidney Disease? What the Largest Trial Found; Can Curcumin Help With Chronic Anterior Uveitis? What the Trials Show.

References

1. DeVan AE, Johnson LC, Brooks FA, et al. "Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress." PMC5310664.
2. Akazawa N, Choi Y, Miyaki A, et al. "Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women." PMID: 23146777.
3. "Curcumin Preparations Can Improve Flow-Mediated Dilation and Endothelial Function: A Meta-Analysis." Complementary Medicine Research. Karger, 2020.
4. Curcumin Supplementation and Vascular and Cognitive Function in Chronic Kidney Disease: A Randomized Controlled Trial. PMC11352164.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.